Unibios Holdings S.A. (BIOSK.AT)
EUR 1.59
(4.28%)
EUR 1.59
(4.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.97 Million | 11.24 Million | 8.47 Million | 7.29 Million | 8.33 Million | 7.98 Million |
| Cost of Revenue | 8.08 Million | 7.04 Million | 5.36 Million | 4.59 Million | 4.9 Million | 4.93 Million |
| Gross Profit | 4.88 Million | 4.19 Million | 3.11 Million | 2.7 Million | 3.43 Million | 3.04 Million |
| Operating Expenses | 1.86 Million | 2.9 Million | 2.46 Million | 2.37 Million | 2.51 Million | 2.86 Million |
| Selling, General and Administrative Expenses | 3.04 Million | 2.94 Million | 2.51 Million | 2.38 Million | 2.53 Million | 2.89 Million |
| Research and Development Expenses | 102.3 Thousand | - | - | - | - | - |
| Other Expenses | -1.28 Million | 69.7 Thousand | 206.83 Thousand | 158.93 Thousand | 16.2 Thousand | 19.14 Thousand |
| Cost and Expenses | 9.95 Million | 9.95 Million | 7.82 Million | 6.97 Million | 7.42 Million | 7.8 Million |
| Operating Income | 3.02 Million | 1.38 Million | 921.24 Thousand | 429.37 Thousand | 758.09 Thousand | 295.56 Thousand |
| Interest Expense | 623.65 Thousand | 391.12 Thousand | 369.61 Thousand | 388.23 Thousand | 453.88 Thousand | 433.11 Thousand |
| Income Tax Expense | 374.24 Thousand | 347.05 Thousand | 217.73 Thousand | 133.33 Thousand | 204.21 Thousand | 122.56 Thousand |
| Earnings before Tax | 2.4 Million | 997.64 Thousand | 551.63 Thousand | 41.15 Thousand | 304.61 Thousand | -203.69 Thousand |
| Net Income | 2.02 Million | 650.59 Thousand | 333.89 Thousand | -92.18 Thousand | 100.4 Thousand | -397.34 Thousand |
| Earnings Per Share Basic | 0.12 | 0.04 | 0.02 | -0.01 | 0.01 | -0.14 |
| Earnings Per Share Diluted | 0.12 | 0.04 | 0.02 | -0.01 | 0.01 | -0.14 |
| Weighted Average Shares Outstanding | 16.95 Million | 15.51 Million | 15.54 Million | 15.57 Million | 15.6 Million | 2.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.95 Million | 15.51 Million | 15.54 Million | 15.57 Million | 15.6 Million | 2.9 Million |
| Gross Margin | 0.38 | 0.37 | 0.37 | 0.37 | 0.41 | 0.38 |
| EBIT Margin | 0.27 | 0.15 | 0.14 | 0.12 | 0.16 | 0.06 |
| Profit Margin | 0.16 | 0.06 | 0.04 | -0.01 | 0.01 | -0.05 |
| EBITDA | 3.45 Million | 1.78 Million | 1.22 Million | 840.35 Thousand | 1.15 Million | 444.12 Thousand |
| Earnings Before Tax Margin | 0.23 | 0.12 | 0.11 | 0.06 | 0.09 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.9 Million | 2.9 Million | 12.97 Million | 3.89 Million | 3.89 Million | 5.19 Million |
| Cost of Revenue | 1.74 Million | 1.74 Million | 8.47 Million | 2.4 Million | 2.4 Million | 3.47 Million |
| Gross Profit | 1.16 Million | 1.16 Million | 4.49 Million | 1.49 Million | 1.49 Million | 1.71 Million |
| Operating Expenses | 801.45 Thousand | 801.45 Thousand | 2.73 Million | 183.3 Thousand | 194.87 Thousand | 1.3 Million |
| Selling, General and Administrative Expenses | 837.34 Thousand | 837.34 Thousand | - | 841.04 Thousand | 841.04 Thousand | 1.3 Million |
| Research and Development Expenses | - | - | - | 51.15 Thousand | 51.15 Thousand | - |
| Other Expenses | -35.88 Thousand | -35.88 Thousand | 78.99 Thousand | -708.88 Thousand | - | - |
| Cost and Expenses | 2.54 Million | 2.54 Million | 11.21 Million | 2.58 Million | 2.59 Million | 4.77 Million |
| Operating Income | 361.23 Thousand | 361.23 Thousand | 1.75 Million | 1.3 Million | 632.81 Thousand | 412.47 Thousand |
| Interest Expense | - | - | 623.65 Thousand | 308.67 Thousand | - | 316.49 Thousand |
| Income Tax Expense | 83.16 Thousand | 83.16 Thousand | 374.24 Thousand | 166.89 Thousand | 166.89 Thousand | 40.45 Thousand |
| Earnings before Tax | 95.18 Thousand | 95.18 Thousand | 2.44 Million | 1.15 Million | 1.15 Million | 101.52 Thousand |
| Net Income | 12.01 Thousand | 12.01 Thousand | 2.02 Million | 987.31 Thousand | 987.31 Thousand | 53.33 Thousand |
| Earnings Per Share Basic | 0.00 | 0.00 | - | 0.05 | 0.05 | 0.00 |
| Earnings Per Share Diluted | 0.00 | 0.00 | - | 0.05 | 0.05 | 0.00 |
| Weighted Average Shares Outstanding | 17.21 Million | 17.21 Million | 16.95 Million | 18.75 Million | 18.75 Million | 15.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.19 Million | 17.19 Million | 16.95 Million | 18.75 Million | 18.75 Million | 15.62 Million |
| Gross Margin | 0.40 | 0.40 | 0.35 | 0.38 | 0.38 | 0.33 |
| EBIT Margin | 0.13 | 0.13 | - | 0.18 | 0.18 | 0.12 |
| Profit Margin | 0.00 | 0.00 | 0.16 | 0.25 | 0.25 | 0.01 |
| EBITDA | 388.81 Thousand | 388.81 Thousand | - | 695.67 Thousand | 695.67 Thousand | 598.83 Thousand |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.14 | 0.34 | 0.16 | 0.08 |
VTS
1082
STARHEALTH
SAMPO
AMAG
CSED3